-
公开(公告)号:US20140243383A1
公开(公告)日:2014-08-28
申请号:US14238777
申请日:2012-08-24
IPC分类号: A61K31/404
CPC分类号: A61K31/404 , A61K9/1623 , A61K9/1635 , A61K9/1641 , A61K9/1652 , A61K9/4858 , A61K31/405
摘要: The present invention discloses a stable pharmaceutical composition comprising: (a) plurality of granules comprising silodosin or salts thereof and one or more pharmaceutical excipients; and (b) an extragranular portion comprising one or more lubricants and optionally one or more surfactants, wherein the granules are free of partially pregelatinized starch.
摘要翻译: 本发明公开了一种稳定的药物组合物,其包含:(a)多种颗粒,其包含西洛多辛或其盐和一种或多种药物赋形剂; 和(b)包含一种或多种润滑剂和任选的一种或多种表面活性剂的颗粒外部分,其中所述颗粒不含部分预胶化淀粉。
-
公开(公告)号:US20140199401A1
公开(公告)日:2014-07-17
申请号:US14130556
申请日:2012-07-04
IPC分类号: A61K47/36 , A61K47/38 , A61K47/26 , A61K31/222 , A61K9/14
CPC分类号: A61K47/36 , A61K9/14 , A61K9/2018 , A61K9/2054 , A61K31/222 , A61K47/26 , A61K47/38
摘要: A stable extend release pharmaceutical composition is disclosed. The composition comprises particles of fesoterodine or salts thereof, one or more rate controlling polymers and one or more pharmaceutically acceptable excipients wherein at least 90% of the total amount of particles of fesoterodine or salts thereof by volume (D90) are having size greater than about 200 microns
摘要翻译: 公开了稳定的延长释放药物组合物。 组合物包含非索特罗定或其盐,一种或多种速率控制聚合物和一种或多种药学上可接受的赋形剂的颗粒,其中非索罗定或其盐的体积(D90)的总量的至少90%具有大于约 200微米
-
公开(公告)号:US20130209553A1
公开(公告)日:2013-08-15
申请号:US13640181
申请日:2011-04-15
申请人: Sunilendu Bhushan Roy , Sushrut Krishnaji Kulkarni , Ajay Kumar Handa , Pranav Dhirajbhai Jogani
发明人: Sunilendu Bhushan Roy , Sushrut Krishnaji Kulkarni , Ajay Kumar Handa , Pranav Dhirajbhai Jogani
IPC分类号: A61K9/20 , A61K31/428
CPC分类号: A61K9/2013 , A61K9/1617 , A61K31/428
摘要: The present invention discloses an extended release pharmaceutical composition of pramipexole or salts thereof comprising at least 40% w/w of hydrogenated castor oil, and one or more pharmaceutically acceptable excipients.
摘要翻译: 本发明公开了普拉克索或其盐的延长释放药物组合物,其包含至少40%w / w的氢化蓖麻油和一种或多种药学上可接受的赋形剂。
-
-